Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
Big Dividends From A Recession-Resistant Portfolio
05:27pm, Wednesday, 07'th Aug 2024
There are growing risks of a recession hitting due to weakening job numbers, rising unemployment, and weakening consumer spending capacity. We share a portfolio of high-yield stocks that should be abl
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
07:30am, Tuesday, 06'th Aug 2024
ZYNLONTA® net sales of $17.0 million in 2Q 2024; Commercial profitability achieved during first half of 2024
Why Agree Realty Stock Jumped Over 11% in July
10:03am, Monday, 05'th Aug 2024
Agree Realty posted strong second-quarter results in July. The REIT also received a credit rating upgrade.
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:05pm, Thursday, 01'st Aug 2024
LAUSANNE, Switzerland, Aug. 01, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced
This High-Yield Dividend Stock Continues to Show Why It's a Phenomenal Passive Income Investment
06:44am, Thursday, 01'st Aug 2024
Agree Realty continues to grow its cash flow, portfolio, and dividend. The REIT enhanced its ability to continue expanding in the first half of this year.
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
A Must-Read Net Lease Masterclass For REIT Investors
07:00am, Wednesday, 31'st Jul 2024
Net lease REITs provide efficient real estate capital for companies, creating wealth for shareholders, employees, and stakeholders. Business model transparency is key for value investing in net lease
Option for an exclusive worldwide license for potential first-in class B7H3/PTK7 topo-I-payload bispecific antibody drug conjugate (BsADC) program B7H3/PTK7 co-expression found in multiple solid tumor
An Important Warning For High-Yield Dividend Stocks
12:35pm, Tuesday, 30'th Jul 2024
High-yield dividend stocks have been rallying on expectations of a Fed rate cut in September. However, I think the market may be overly optimistic. I share the main headwind likely facing high-yield s
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
07:15am, Tuesday, 30'th Jul 2024
LAUSANNE, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced
Agree Realty Receives Upgrade to BBB+ From S&P Global Ratings
04:25pm, Monday, 29'th Jul 2024
Highlights Highly Occupied Portfolio and Sector Leading Investment Grade Tenant Base ROYAL OAK, Mich., July 29, 2024 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today anno
Agree Realty Is Set To Outperform Its Peers: Here's Why
10:24am, Monday, 29'th Jul 2024
Agree Realty is still attractive after a recent stock price increase. ADC has top-tier portfolio quality reflected within its occupancy rate, WALT, and share of ABR derived from investment-graded tena
Agree Realty: Better Than Realty Income For Most Investors
08:46am, Monday, 29'th Jul 2024
Agree Realty: Better Than Realty Income For Most Investors
Agree Realty: A Rock Solid Option For Income And Safety
08:45am, Monday, 29'th Jul 2024
Agree Realty Corporation offers a reliable 4.3% dividend yield, 2% rent growth, and potential for multiple expansion. ADC's focus on larger properties with high-quality tenants and ground leases resul
Agree Realty: Not As Attractive, But Still Bullish (Rating Downgrade)
08:00am, Monday, 29'th Jul 2024
I think Agree Realty will likely to outperform the S&P in total returns over the next 5-10 years. ADC has shown strong growth with impressive earnings and acquisitions over the past year. Additionally
